New GF(2n) Parallel Multiplier Using Redundant Representation

A new GF(2n) redundant representation is presented. Squaring in the representation is almost cost-free. Based on the representation, two multipliers are proposed. The XOR gate complexity of the first multiplier is lower than a recently proposed normal basis multiplier when CN (the complexity of the basis) is larger than 3n-1

Normal Basis Multiplication Algorithms for GF(2n) (Full Version)

In this paper, we propose a new normal basis multiplication algorithm for GF(2n). This algorithm can be used to design not only fast software algorithms but also low complexity bit-parallel multipliers in some GF(2n)s. Especially, for some values of n that no Gaussian normal basis exists in GF(2n), i.e., 8|n, this algorithm provides an alternative way to construct low complexity normal basis multipliers. Two improvements on a recently proposed software normal basis multiplication algorithm are also presented. Time and memory complexities of these normal basis multiplication algorithms are compared with respect to software performance. It is shown that they have some specific behavior in different applications. For example, GF(2571) is one of the five binary fields recommended by NIST for ECDSA (Elliptic Curve Digital Signature Algorithm) applications. In this field, our experiments show that the new algorithm is even faster than the polynomial basis Montgomery multiplication algorithm: 525 us v. 819 us

Characterization of cellulase production by carbon sources in two Bacillus species

The induction of cellulase production in two Bacillus spp. was studied by means of measuring cellulase activities under the condition of different carbon sources. The results indicate that cellulase could not be induced by cellulose material as a sole carbon source. Instead, they could be induced by monosaccharide or disaccharide with reducing group. Moreover, the expression of cellulase components was synergistic. When cell wall/envelope enzyme and endoenzyme from two Bacillus spp. acted on these inducers, analysis of reaction products by high performance liquid chromatography (HPLC) revealed that cell wall/envelope enzyme and endoenzyme from two Bacillus spp. were inactive on these inducers. It also indicated that these inducers entered cells directly and served function of induction.Keywords: Bacillus, cellulase, induction, carbon source

Longitudinal Genomic Evolution of Conventional Papillary Thyroid Cancer With Brain Metastasis

BackgroundBrain metastasis is extremely rare but predicts dismal prognosis in papillary thyroid cancer (PTC). Dynamic evaluation of stepwise metastatic lesions was barely conducted to identify the longitudinal genomic evolution of brain metastasis in PTC.MethodChronologically resected specimen was analyzed by whole exome sequencing, including four metastatic lymph nodes (lyn 1–4) and brain metastasis lesion (BM). Phylogenetic tree was reconstructed to infer the metastatic pattern and the potential functional mutations.ResultsContrasting with lyn1, ipsilateral metastatic lesions (lyn2–4 and BM) with shared biallelic mutations of TSC2 indicated different genetic originations from multifocal tumors. Lyn 3/4, particularly lyn4 exhibited high genetic similarity with BM. Besides the similar mutational compositions and signatures, shared functional mutations (CDK4R24C, TP53R342*) were observed in lyn3/4 and BM. Frequencies of these mutations gradually increase along with the metastasis progression. Consistently, TP53 knockout and CDK4R24C introduction in PTC cells significantly decreased radioiodine uptake and increased metastatic ability.ConclusionGenomic mutations in CDK4 and TP53 during the tumor evolution may contribute to the lymph node and brain metastasis of PTC

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016) : part two

Background The immunological escape of tumors represents one of the main ob- stacles to the treatment of malignancies. The blockade of PD-1 or CTLA-4 receptors represented a milestone in the history of immunotherapy. However, immune checkpoint inhibitors seem to be effective in specific cohorts of patients. It has been proposed that their efficacy relies on the presence of an immunological response. Thus, we hypothesized that disruption of the PD-L1/PD-1 axis would synergize with our oncolytic vaccine platform PeptiCRAd. Methods We used murine B16OVA in vivo tumor models and flow cytometry analysis to investigate the immunological background. Results First, we found that high-burden B16OVA tumors were refractory to combination immunotherapy. However, with a more aggressive schedule, tumors with a lower burden were more susceptible to the combination of PeptiCRAd and PD-L1 blockade. The therapy signifi- cantly increased the median survival of mice (Fig. 7). Interestingly, the reduced growth of contralaterally injected B16F10 cells sug- gested the presence of a long lasting immunological memory also against non-targeted antigens. Concerning the functional state of tumor infiltrating lymphocytes (TILs), we found that all the immune therapies would enhance the percentage of activated (PD-1pos TIM- 3neg) T lymphocytes and reduce the amount of exhausted (PD-1pos TIM-3pos) cells compared to placebo. As expected, we found that PeptiCRAd monotherapy could increase the number of antigen spe- cific CD8+ T cells compared to other treatments. However, only the combination with PD-L1 blockade could significantly increase the ra- tio between activated and exhausted pentamer positive cells (p= 0.0058), suggesting that by disrupting the PD-1/PD-L1 axis we could decrease the amount of dysfunctional antigen specific T cells. We ob- served that the anatomical location deeply influenced the state of CD4+ and CD8+ T lymphocytes. In fact, TIM-3 expression was in- creased by 2 fold on TILs compared to splenic and lymphoid T cells. In the CD8+ compartment, the expression of PD-1 on the surface seemed to be restricted to the tumor micro-environment, while CD4 + T cells had a high expression of PD-1 also in lymphoid organs. Interestingly, we found that the levels of PD-1 were significantly higher on CD8+ T cells than on CD4+ T cells into the tumor micro- environment (p < 0.0001). Conclusions In conclusion, we demonstrated that the efficacy of immune check- point inhibitors might be strongly enhanced by their combination with cancer vaccines. PeptiCRAd was able to increase the number of antigen-specific T cells and PD-L1 blockade prevented their exhaus- tion, resulting in long-lasting immunological memory and increased median survival

Normal Basis Multiplication Algorithm for GF(2^n)

In this paper, we propose a new normal basis multiplication algorithm for GF(2 )

Two Software Normal Basis Multiplication Algorithms for GF(2^n)

In this paper, two different normal basis multiplication algorithms for software implementation are proposed over GF(2^n). The first algorithm is suitable for high complexity normal bases and the second algorithm is fast for type-I optimal normal bases and low complexity normal bases. The ANSI C source program is also included in this paper